Activating Collaborative CIS Support Via Targeted Provider Mailing

Northwestern University logo

Northwestern University

Status

Completed

Conditions

Precancerous Condition

Treatments

Other: CIS support mailing intervention
Other: Usual care mailing intervention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00873288
R21CA126450 (U.S. NIH Grant/Contract)
CDR0000626557
P30CA060553 (U.S. NIH Grant/Contract)
NU-1719-007

Details and patient eligibility

About

RATIONALE: Receiving a reminder letter from their doctor with questions to ask the Cancer Information Service may be more effective than a standard reminder letter in helping patients who have had an abnormal Pap test keep their follow-up colposcopy appointment. PURPOSE: This randomized clinical trial is studying a personalized letter with Cancer Information Service support to see how well it works compared with a standard reminder letter in women scheduled for colposcopy after an abnormal Pap test.

Full description

OBJECTIVES: Compare the effect of a usual care mailing intervention vs a Cancer Information Service (CIS) support mailing intervention on the likelihood that women with an abnormal Pap test will keep their medical follow-up appointments and be satisfied with how they talk to their provider. OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 intervention arms. Arm I (Usual-care mailing intervention): Patients receive a generic letter reminding them of their follow-up colposcopy appointment. Arm II (Cancer Information Service [CIS] support mailing intervention): Patients receive a targeted letter reminding them of their follow-up colposcopy appointment, asking them or someone they designate to call the CIS, and suggesting some questions to ask the CIS about colposcopies and Pap tests. At their follow-up appointments, all patients undergo an exit interview to compare patient satisfaction between the 2 interventions. Patients in arm II also answer questions about their CIS experience, and if the intervention made their follow-up visit less difficult.

Enrollment

254 patients

Sex

Female

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

DISEASE CHARACTERISTICS:

  • Received an abnormal Pap test result
  • Scheduled for a colposcopy within 6 months of their Pap test at either the Erie Family Health Center or the Prentice Ambulatory Clinic

PATIENT CHARACTERISTICS:

  • Female
  • Able to communicate in either English or Spanish
  • Clinic staff will review patient charts to determine eligibility

PRIOR CONCURRENT THERAPY:

  • Not specified

Exclusion criteria

  • <18 years
  • unable to communicate in English or Spanish
  • no address to which a letter can be mailed

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

254 participants in 2 patient groups

Usual Care mailing intervention
Active Comparator group
Description:
routine colposcopy reminder letter mailed
Treatment:
Other: Usual care mailing intervention
CIS support mailing intervention
Experimental group
Description:
Mailed reminder plus provider recommendation to call CIS and sample questions to ask
Treatment:
Other: CIS support mailing intervention

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems